Skip to main content
. Author manuscript; available in PMC: 2010 Jun 15.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 24;877(18-19):1709–1715. doi: 10.1016/j.jchromb.2009.04.025

Figure 6.

Figure 6

Cyclophosphamide and CEPM plasma concentration–time profile in a pediatric patient after two cyclophosphamide doses of 2 g/m2 given as 1 hr intravenous infusions. Plasma cyclophosphamide concentration–time points (●) are plotted and the solid line represents the best-fit curve resulting from the pharmacokinetic analysis. Plasma CEPM concentration-time points (▲) are plotted and the dashed line represents the best-fit curve resulting from the pharmacokinetic analysis.